Safety and Effectiveness Study of Combo Bio-engineered Sirolimus Eluting Stent

NCT00967902 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Lesions

Interventions

DEVICE: coronary stenting

Sponsor

OrbusNeich